New study maps HPV's role in anal cancer across china
NCT ID NCT06670495
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to understand which types of HPV are linked to anal cancer in China and how common the disease is. Researchers will collect samples and health data from 300 patients across multiple hospitals. The goal is to learn more about the virus and disease patterns, not to test a new treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help guide future prevention strategies, like HPV vaccination, to reduce anal cancer in China.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly help participants and may not lead to immediate changes in care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fudan University Shanghai Cancer Center
RECRUITINGShanghai, 200032, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an immunotherapy drug boost the power of chemoradiation against anal cancer?
- Can anal cancer treatment spare sexual well-being? a study tracks the toll over two years.
- HIV and cancer: study seeks to uncover hidden risk factors
- What do gay men know about anal cancer screening? a new survey aims to find out
- New drug combo targets HPV-Driven cancers in phase II trial
- Vitamins e and CoQ10 tested as shield against radiation damage